769-11-9

Basic information

• Product Name: 2-CHLORO-6-NITROANILINE
• Synonyms: 2-CHLORO-6-NITROANILINE;2-CHLORO-6-NITRO-PHENYLAMINE;2-Chloro-6-nitroaniline 97%;2-Chloro-6-nitrobenzenamine;2-Nitro-6-chloroaniline;2-Amino-3-chloronitrobenzene;2-Chloro-6-nitroaniline, 95+%;Benzenamine, 2-chloro-6-nitro-
• CAS NO: 769-11-9
• Molecular Formula: C₆H₅ClN₂O₂
• Molecular Weight: 172.57
• EINECS: 212-204-9
• Mol File: 769-11-9.mol
• Article Data: 12

Chemical Properties

• Melting Point: 74-75 °C
• Boiling Point: 284.3 °C at 760 mmHg
• Flash Point: 125.8 °C
• Appearance: /
• Density: 1.494 g/cm³
• Vapor Pressure: 0.003mmHg at 25°C
• Refractive Index: 1.646
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: pK1: 2.41(+1) (25°C)
• CAS DataBase Reference: 2-CHLORO-6-NITROANILINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-6-NITROANILINE(769-11-9)
• EPA Substance Registry System: 2-CHLORO-6-NITROANILINE(769-11-9)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 769-11-9(Hazardous Substances Data)

Usage

General Description

2-Chloro-6-nitroaniline is a chemical compound with the molecular formula C6H5ClN2O2. It is a pale yellow solid that is primarily used in the manufacturing of dyes and pigments. 2-CHLORO-6-NITROANILINE is classified as a nitroaniline, which means it contains a nitro group (NO2) and an aniline group (C6H5NH2) in its molecular structure. 2-Chloro-6-nitroaniline is commonly used in the production of azo dyes, which are important in various industries such as textiles, plastics, and printing. 2-CHLORO-6-NITROANILINE is considered to be toxic and potentially harmful if ingested or inhaled, and safety precautions should be taken when handling it.

InChI:InChI=1/C6H5ClN2O2/c7-4-2-1-3-5(6(4)8)9(10)11/h1-3H,8H2

Upstream product

• 7664-93-9 sulfuric acid 
• 88-74-4 2-nitro-aniline 
• 7647-01-0 hydrogenchloride 
• 97-00-7 1-chloro-2,4-dinitro-benzene 
• 602-03-9 2,3-dinitroaniline 
• 121-73-3 3-Nitrochlorobenzene 
• 602-02-8 2,3-dinitrochlorobenzene 
• 7664-41-7 ammonia 
• 59483-70-4 N,N-dichloro-2-nitroaniline 
• 1516-58-1 o-azidonitrobenzene 
• 95-51-2 o-chloroaniline 
• 533-17-5 N-(2-chlorophenyl)acetamide 
• 507-40-4 tert-butylhypochlorite 
• 72487-80-0 N-(2-chloro-6-nitrophenyl)acetanilide 

Downstream Products

• 32337-97-6 1-chloro-2-iodo-3-nitrobenzene 
• 105905-39-3 bis-(2-chloro-6-nitro-phenyl)-diazene 
• 19128-48-4 2-bromo-1-chloro-3-nitro-benzene 
• 3209-22-1 1,2-Dichloro-3-nitrobenzene 
• 141075-07-2 N-(2-Chloro-6-nitro-phenyl)-formamide 
• 100141-90-0 N-butyl-glycine-(2-chloro-6-nitro-anilide) 
• 89639-96-3 2-chloro-6-nitrophenyl methyl thioether 
• 91912-35-5 Methyl-(2-nitro-6-chlor-phenyl)-sulfon 
• 1202512-88-6 C₉H₉ClN₂O₂ 
• 61861-90-3 3-methyl-7-nitro-1H-indole 
• 1352547-47-7 C₁₆H₉BrCl₂N₆O₃S 
• 5918-97-8 4-chloro-1,3-dihydro-2H-benzoimidazol-2-one 
• 5227-60-1 5-chloro-2,3-diphenylquinoxaline 
• 72995-15-4 5-chloro-3,4-dihydro-2(1H)-quinolinone 

Relevant articles and documents

Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulators

Recent studies examined the possibility to overcome imatinib resistance in chronic myeloid leukemia (CML) patients by combination therapy with peroxisome proliferator-activated receptor gamma (PPARγ) ligands. Pioglitazone, a full PPARγ agonist, improved the survival of patients by the gradual elimination of the residual CML stem cell pool. To evaluate the importance of the pharmacological profile of PPARγ agonists on the ability to circumvent resistance, the partial PPARγ agonist 4‘-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-[1,1’-biphenyl]-2-carboxylic acid, derived from telmisartan, and other related derivatives were investigated. The 4-substituted benzimidazole derivatives bearing a [1,1′-biphenyl]-2-carboxamide moiety sensitized K562-resistant cells to imatinib treatment. Especially the derivatives 18a-f, which did not activate PPARγ to more than 40% at 10 μM, retrieved the cytotoxicity of imatinib in these cells. The cell death modulating properties were higher than that of pioglitazone. It is of interest to note that all novel compounds were not cytotoxic neither on non-resistant nor on resistant cells. They exerted antitumor potency only in combination with imatinib.

ALDOSTERONE SYNTHASE INHIBITORS

This invention relates to tricyclic triazole analogues of the formula I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.

A convenient copper-catalyzed direct animation of nitroarenes with 9-alkylhydroxylamines

O-Alkylhydroxylamines, particularly O-methylhydroxylamine, aminate nitroarenes in the presence of a strong base and a copper catalyst to give aminonitroarenes in good yields, ortho- or para-Animation with respect to the nitro group takes place, and in some cases the ortho-aminated product is preferentially obtained. With 3-substituted nitrobenzenes where the substituent has a lone pair of electrons, preferential amination occurs at the 2-position to give the sterically most congested 3c-f, 14 and 22g.